Previous Page  20 / 32 Next Page
Information
Show Menu
Previous Page 20 / 32 Next Page
Page Background

Page 52

Notes:

conferenceseries

.com

Volume 4

Toxicology: Open Access

ISSN: 2476-2067

Toxicology Congress 2018

March 12-14, 2018

March 12-14, 2018 Singapore

14

th

World Congress on

Toxicology and Pharmacology

Intravenous iron sucrose and oral iron therapy in iron deficiency anemia during pregnancy: A

comparative study in Indian population

Siva V K and Sankaran P K

Saveetha Medical College, India

Background:

Nutritional anemia is one of major the contributory factor in high maternal mortality and morbidity in most of

the countries. Iron deficiency is the principle cause for nutritional anemia.

Objective:

To compare the efficacy of oral iron therapy with intravenous iron therapy in the treatment of iron deficiency

anemia during pregnancy.

Methodology:

This comparative study was undertaken at a tertiary care teaching hospital among 110 pregnant anemic patients

whose baseline hemoglobin and serum ferritin levels were recorded prior to treatment. The patients were divided into two

groups; group A (n=58) received intravenous iron-sucrose and group B (n=52) received oral iron therapy. The patients were

followed up for further investigations and side effects.

Results:

Out of 110 patients, 50% had mild anemia (10.9-10 gm%), 34.5% patients had moderate anemia (7-9.9 gm%) and 15.5%

(6-6.9 gm%) patients had severe anemia. Group A showed statistically significant rise in hemoglobin regardless the severity.

Conclusion:

Intravenous iron-sucrose administration increased hemoglobin level and serum ferritin levels more rapidly,

without any serious adverse effect in comparison with oral ferrous sulfate in women with iron deficiency anemia in pregnancy.

Biography

Siva V K is currently pursuing MBBS from Saveetha Medical College, SIMATS.

sivavk2@gmail.com

Siva V K et al., Toxicol Open Access 2018, Volume 4

DOI: 10.4172/2476-2067-C1-005